Literature DB >> 2380350

Antibody to cytotoxin in infection by Helicobacter pylori.

R D Leunk1, M A Ferguson, D R Morgan, D E Low, A E Simor.   

Abstract

Gastrointestinal disease and colonization by Helicobacter pylori were determined in 36 asymptomatic volunteers and 30 symptomatic individuals undergoing endoscopy and biopsy. Serum antibody immunoglobulin G (IgG) and IgA to H. pylori were measured by enzyme-linked immunosorbent assay. Serum antibody to a cytotoxin produced by H. pylori was detected with a neutralization assay. Serum IgG was 95% predictive of infection by H. pylori, and serum IgA was 88% predictive. Antibody to the cytotoxin was detected in 12 of 18 infected individuals. Antibody to the cytotoxin was a highly specific (96%), but not a very sensitive (67%), indicator of infection by H. pylori. The neutralization assay was 87% predictive of infection. These data confirm the diagnostic value of serum antibody to H. pylori for the detection of infection. The toxin-neutralizing activity of sera from individuals infected with H. pylori suggests that the cytotoxin is produced in vivo. It may therefore contribute to disease associated with H. pylori.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380350      PMCID: PMC267901          DOI: 10.1128/jcm.28.6.1181-1184.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  The prevalence of Campylobacter pylori gastritis among asymptomatic adults.

Authors:  D B Gregson; D E Low; M M Cohen; N B Cooter; J J Connon; S L Wolman; A E Simor
Journal:  CMAJ       Date:  1989-06-15       Impact factor: 8.262

2.  Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy.

Authors:  L Booth; G Holdstock; H MacBride; P Hawtin; J R Gibson; A Ireland; J Bamforth; C E DuBoulay; R S Lloyd; A D Pearson
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

3.  Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population.

Authors:  D M Jones; J Eldridge; A J Fox; P Sethi; P J Whorwell
Journal:  J Med Microbiol       Date:  1986-08       Impact factor: 2.472

4.  Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C. pyloridis in the gastric mucosa.

Authors:  C S Goodwin; E Blincow; G Peterson; C Sanderson; W Cheng; B Marshall; J R Warren; R McCulloch
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  Campylobacter pylori antibodies in humans.

Authors:  G I Perez-Perez; B M Dworkin; J E Chodos; M J Blaser
Journal:  Ann Intern Med       Date:  1988-07-01       Impact factor: 25.391

6.  The use of serology to diagnose active Campylobacter pylori infection.

Authors:  H M Mitchell; A Lee; J Berkowicz; T Borody
Journal:  Med J Aust       Date:  1988 Dec 5-19       Impact factor: 7.738

7.  Growth of Campylobacter pylori in liquid media.

Authors:  D R Morgan; R Freedman; C E Depew; W G Kraft
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

8.  Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; S E Shires; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

9.  Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study.

Authors:  V Tricottet; P Bruneval; O Vire; J P Camilleri; F Bloch; N Bonte; J Roge
Journal:  Ultrastruct Pathol       Date:  1986       Impact factor: 1.094

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  13 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

Authors:  M Donati; S Moreno; E Storni; A Tucci; L Poli; C Mazzoni; O Varoli; V Sambri; A Farencena; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 3.  Pathogenicity of Helicobacter pylori: a perspective.

Authors:  A Lee; J Fox; S Hazell
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

4.  Systemic and local immune responses against Helicobacter pylori urease in patients with chronic gastritis: distinct IgA and IgG productive sites.

Authors:  S Futagami; H Takahashi; Y Norose; M Kobayashi
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

5.  Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin.

Authors:  T L Cover; W Puryear; G I Perez-Perez; M J Blaser
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 6.  Metabolism and genetics of Helicobacter pylori: the genome era.

Authors:  A Marais; G L Mendz; S L Hazell; F Mégraud
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

7.  High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan.

Authors:  K Ogura; F Kanai; S Maeda; H Yoshida; M Ogura; K H Lan; K Hirota; T Kawabe; Y Shiratori; M Omata
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

8.  Inability of an isogenic urease-negative mutant stain of Helicobacter mustelae to colonize the ferret stomach.

Authors:  K A Andrutis; J G Fox; D B Schauer; R P Marini; J C Murphy; L Yan; J V Solnick
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.

Authors:  T L Cover; P Cao; U K Murthy; M S Sipple; M J Blaser
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases.

Authors:  W Tee; J R Lambert; B Dwyer
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.